Voya Investment Management LLC Moon Lake Immunotherapeutics Transaction History
Voya Investment Management LLC
- $71.9 Billion
- Q1 2025
A detailed history of Voya Investment Management LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Voya Investment Management LLC holds 392,924 shares of MLTX stock, worth $15.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
392,924
Previous 448,860
12.46%
Holding current value
$15.8 Million
Previous $23.9 Million
35.64%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding MLTX
# of Institutions
155Shares Held
54.4MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$794 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$341 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$119 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$111 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$59.4 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.48B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...